In this cohort study, patients with early-stage, low-grade endometrial cancer who did not undergo hysterectomy, specifically ...
Durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer (EC ...
How is the current clinical management of endometrial cancer worldwide? An international survey by the North-Eastern German Society of Gynaecological Oncology (NOGGO). This is an ASCO Meeting Abstract ...
A 55-year-old woman presented with a pelvic mass and was found to have a tumor arising from the uterus. She had undergone bilateral oophorectomy 15 years previously for "ruptured abscesses." At ...
The role of adjuvant therapy in stage I grade 3 endometrioid endometrial carcinoma (EEC) is debatable. We sought to define the agreement between Post Operative Radiation Therapy in Endometrial ...
A small percentage of ovarian cancers are hereditary, driven by inherited mutations in genes such as BRCA1 and BRCA2. Most ovarian cancers are “sporadic,” however, meaning they are driven by mutations ...
Mesonephric carcinoma (MC) is a rare cervical adenocarcinoma originating from mesonephric remnants, characterized by diverse architectural patterns and a distinct immunophenotype. A subset of ...
(a) The tumor shows focal glandular architecture along with solid areas (100×, H&E). (b, c) The solid component exhibits prominent lymphocytic infiltrate with tumor heterogeneity (100×, H&E). (d) The ...
—These investigators compared criteria from the two commonly used pathologic risk classification systems for endometrial carcinoma, assessed their concordance with molecular subtypes, and evaluated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback